Insider Trading History of Edwards Mark G

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Edwards Mark G since 2011. The trader's CIK number is 1190429. At the time of the last reporting, Edwards Mark G was the Director of Acelrx Pharmaceuticals Inc. (stock ticker symbol ACRX). Also see all insider trading activities at Acelrx Pharmaceuticals Inc.


Yearly summary of insider trading at Acelrx Pharmaceuticals Inc (ACRX) by Edwards Mark G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 ACRX 59,000 $134,271 0 $0 0 $0
2018 ACRX 31,000 $90,171 0 $0 0 $0
2017 ACRX 35,000 $72,070 0 $0 0 $0
2016 ACRX 15,000 $47,250 0 $0 0 $0
2015 ACRX 40,000 $125,120 0 $0 0 $0
2013 ACRX 10,000 $81,000 0 $0 0 $0
2011 ACRX 50,000 $143,900 0 $0 0 $0


Insider trading of Acelrx Pharmaceuticals Inc (ACRX) by Edwards Mark G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-11-12 ACRX Buy 25,000 1.78 44,575
2019-08-23 ACRX Buy 10,000 2.20 21,960
2019-08-26 ACRX Buy 5,000 2.17 10,850
2019-03-12 ACRX Buy 19,000 2.99 56,886
2018-11-15 ACRX Buy 20,700 2.82 58,374
2018-08-07 ACRX Buy 5,300 2.84 15,062
2018-06-01 ACRX Buy 300 3.30 990
2018-06-05 ACRX Buy 4,700 3.35 15,745
2017-11-14 ACRX Buy 30,000 1.90 56,970
2017-08-22 ACRX Buy 200 2.90 580
2017-08-24 ACRX Buy 4,800 3.02 14,520
2016-05-10 ACRX Buy 5,000 3.25 16,250
2016-05-11 ACRX Buy 5,000 3.15 15,750
2016-05-12 ACRX Buy 5,000 3.05 15,250
2015-05-07 ACRX Buy 40,000 3.13 125,120
2013-06-06 ACRX Buy 10,000 8.10 81,000
2011-12-01 ACRX Buy 10,000 2.79 27,900
2011-11-14 ACRX Buy 40,000 2.90 116,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Edwards Mark G (Director of Acelrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.